Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey

Hepatology International - Tập 7 - Trang 714-720 - 2013
Shaoli You1, Yihui Rong1, Bing Zhu1, Aimin Zhang1, Hong Zang1, Hongling Liu1, Dongze Li1, Zhihong Wan1, Shaojie Xin1
1Liver Failure Treatment and Research Center, Beijing 302 Hospital, Beijing, China

Tóm tắt

To investigate the etiological characteristics of patients with liver failure in the past 10 years. Clinical and investigational data in hospitalized patients with liver failure admitted from 2002 to 2011 were retrospectively analyzed. Standard definitions and criteria were used to assess disease etiology. Of these 3,916 patients, 3,429 (87.6 %) had acute-on-chronic liver failure (ACLF), 114 (2.9 %) acute liver failure (ALF), and 373 (9.5 %) subacute liver failure. Viral infection was the most common cause of liver failure in the 3,295 patients (84.1 %). Hepatitis of unknown etiology was deemed responsible for 371 cases of liver failure (9.5 %). Drug-induced liver injury, alcoholic hepatitis, and autoimmune hepatitis led to 120 cases (3.1 %), 109 cases (2.8 %), and 19 cases (0.5 %), respectively. The most common cause of ACLF was HBV infection (87.3 %), while the main causes of acute and subacute liver failure were hepatitis of unknown etiology (39.4 %), viral infection (36.6 %), and drug-induced liver injury (19.3 %). Our data showed that the incidence of liver failure caused by HBV gradually decreased from 86.5 % in 2002 to 69.2 % in 2011. However, the incidence of hepatitis of unknown etiology, drug-induced liver injury, and alcoholic hepatitis was increased. HBV infection is the main cause of liver failure in China. However, the incidence of HBV-related liver failure has gradually decreased in the past 10 years. Hepatitis of unknown etiology has replaced HBV infection as the most common apparent cause of acute liver failure.

Tài liệu tham khảo

Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology. Diagnostic and treatment guidelines for liver failure. Zhonghua Gan Zang Bing Za Zhi. 2006;14:643–646

Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure; consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009;3:269–282

Williams R, Wendon J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology. 1994;20:S5–S10

Lee WM, Squires RH, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–1415

Areia M, Romaozinho JM, Ferreira M, Amaro P, Leitao MC. Fulminant hepatic failure: a Portuguese experience. Eur J Gastroenterol Hepatol. 2007;19:665–669

Escorsell A, Mas A, de la Mata M. Acute liver failure in Spain: analysis of 267 cases. Liver Transpl. 2007;13:1389–1395

Ke WM, Ye YN, Huang S. Discriminate function for prognostic indexes and probability of death in chronic severe hepatitis B. J Gastroenterol. 2003;38:861–864

Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S158–S168

Hiramatsu A, Takahashi S, Aikata H, Azakami T, Katamura Y, Kawaoka T, et al. Etiology and outcome of acute liver failure: retrospective analysis of 50 patients treated at a single center. J Gastroenterol Hepatol. 2008;23:1216–1222

Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transpl. 2008;14:S67–S79

Huang K, Hu JH, Wang HF, He WP, Chen J, Duan XZ, et al. Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure. World J Gastroenterol. 2011;17:3448–3452

Liu C, Wang YM, Fan K. Epidemiological and clinical features of hepatitis B virus related liver failure in China. World J Gastroenterol. 2011;17:3054–3059

Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig Dis Sci. 1998;43:1311–1316

Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954

Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology. Management scheme of diagnostic and therapeutic criteria of viral hepatitis. Zhonghua Gan Zang Bing Za Zhi. 2000;8:324–329

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–938

The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease for the Chinese Liver Disease Association. Guidelines for management of alcoholic liver disease-an updated and revised edition. Zhonghua Gan Zang Bing Za Zhi. 2010;18:163–166

Collaborative Group of Hepatobiliary Disease of Digestive Disease Branch of Chinese Medical Association. Recommendation of management for drug induced acute liver injury (Protocol). Chinese Journal of Digestion. 2007;27:765–767

Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology. 2008;47:2089–2111

Smith ID, Simpson KJ, Garden OJ, Wigmore SJ. Nonparacetamol drug-induced fulminant hepatic failure among adults in Scotland. Eur J Gastroenterol Hepatol. 2005;17:161–167

Miyake Y, Iwasaki Y, Makino Y, Kobashi H, Takaguchi K, Ando M, et al. Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non-acetaminophen-related fulminant hepatic failure. J Gastroenterol Hepatol. 2007;22:855–861

Furukawa M, Kasajima S, Nakamura Y. Toxic hepatitis induced by show-wu-pian, a Chinese herbal preparation. Intern Med. 2010;49:1537–1540

Wang YP, Shi B, Chen YX, Xu J, Jiang CF, Xie WF. Drug-induced liver disease: an 8-year study of patients from one gastroenterological department. J Dig Dis. 2009;10:195–200

Brandsaeter B, Hockerstedt K, Friman S, Ericzon BG, Kirkegaard P, Isoniemi H, et al. Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation—12 years experience in the Nordic countries. Liver Transpl. 2002;8:1055–1062

Oketani Makoto, Ido Akio, Tsubouchi Hirohito. Changing etiologies and outcomes of acute liver failure: a perspective from Japan. J Gastroenterol Hepatol. 2011;26:65–71

Centers for Disease Control and Prevention (CDC). Progress in hepatitis B prevention through universal infant vaccination—China, 1997–2006. MMWR Morb Mortal Wkly Rep. 2007;56:441–445

Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis. 2012;16:e82–e88

Hadem J, Stiefel P, Bahr MJ, Tillmann HL, Rifai K, Klempnauer J, et al. Prognostic implications of lactate, bilirubin, and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol. 2008;6:339–345

Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK, et al. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis. 2012;44:166–171

Thông tin
Thông tin xuất bản

Hepatology International

Tập 7

714-720

Thông tin tác giả